Ampio Pharmaceuticals Inc at ROTH Medtech Innovation Forum (Virtual) Transcript
Everyone. My name is David Bar-Or. I am a physician. And I'm be -- presenting on behalf of Ampio drug, Ampion, for the treatment of COVID-19. I will be a little briefer than the previous discusser by not going too much into the science.
Can you move the next slide? Does we have -- we are a public company as well. Those are the forward-looking statements that we have to flip to before on slide. Next slide. This is myself. You see my picture. It being brief, I'm a physician. I am also a scientist. I have a background in molecular biology and biochemistry. And I am a co-founder of Ampio with Mr. Michael Macaluso. I currently preside over a six Level I trauma centers research programs all over the country and also run the stroke research program at the Swedish Medical Center in Englewood, Colorado.
Next, so a brief overview of the company. Ampio is a company that we founded based on in-house developed and invented implemented the technology to advance immunology-based therapies for very prevalent inflammatory conditions. One
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
